Filana Therapeutics Inc.
FLNA | NASDAQ
$0.62
-$0.04 (-5.78%)
At close: Oct 30, 2026, 4:00 PM ET
$0.65
+$0.03 (+4.95%)
Pre-market:
Nov 2, 2026, 7:51 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -90.97M |
Depreciation & Amortization | 936K |
Stock-Based Compensation | n/a |
Other Working Capital | 4.21M |
Other Non-Cash Items | 19.58M |
Deferred Income Tax | n/a |
Change in Working Capital | 38.2M |
Operating Cash Flow | -32.25M |
Capital Expenditures | -581K |
Cash Acquisitions | n/a |
Purchase of Investments | n/a |
Sales Maturities Of Investments | n/a |
Other Investing Acitivies | n/a |
Investing Cash Flow | -581K |
Debt Repayment | n/a |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | n/a |
Financial Cash Flow | -239K |
Net Cash Flow | -33.07M |
Free Cash Flow | -32.83M |
Adj. Free Cash Flow | -32.83M |
Maintenance CapEx | -581K |
Growth CapEx | n/a |
Owner Earnings | -32.83M |
Add to Watchlist
Select watchlists to add or remove FLNA